Details for New Drug Application (NDA): 022003
✉ Email this page to a colleague
The generic ingredient in NOXAFIL is posaconazole. There are twenty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the posaconazole profile page.
Summary for 022003
Tradename: | NOXAFIL |
Applicant: | Schering |
Ingredient: | posaconazole |
Patents: | 0 |
Suppliers and Packaging for NDA: 022003
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003 | NDA | Merck Sharp & Dohme LLC | 0085-1328 | 0085-1328-01 | 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) / 105 mL in 1 BOTTLE, GLASS |
NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003 | NDA AUTHORIZED GENERIC | ENDO USA, Inc. | 0254-1016 | 0254-1016-36 | 1 BOTTLE, GLASS in 1 CARTON (0254-1016-36) / 105 mL in 1 BOTTLE, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 40MG/ML | ||||
Approval Date: | Sep 15, 2006 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 022003
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003-001 | Sep 15, 2006 | ⤷ Subscribe | ⤷ Subscribe |
Schering | NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003-001 | Sep 15, 2006 | ⤷ Subscribe | ⤷ Subscribe |
Schering | NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003-001 | Sep 15, 2006 | ⤷ Subscribe | ⤷ Subscribe |
Schering | NOXAFIL | posaconazole | SUSPENSION;ORAL | 022003-001 | Sep 15, 2006 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription